These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 184507)

  • 1. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
    Loizzi P; Terlizzi N
    Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U; Johannes KJ
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
    MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
    Neuman J; de Neuman MP; Talmasky S; Pesce R; Valero E; Martiarena JL
    J Cardiovasc Surg (Torino); 1973; Spec No():532-7. PubMed ID: 4377715
    [No Abstract]   [Full Text] [Related]  

  • 6. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
    Jung W; Kremer GJ; Müller D
    MMW Munch Med Wochenschr; 1975 Oct; 117(44):1783-6. PubMed ID: 171564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physician's guide to hyperlipidemia.
    Fredrickson DS
    Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
    Jantke J; Schwartzkopff W; Zschiedrich M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():392-5. PubMed ID: 206057
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
    Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD
    Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
    Vogelberg KH; Althoff B; Heggen EM; Thesseling W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():832-5. PubMed ID: 196437
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of hyperlipidemias].
    Wolfram G
    Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700
    [No Abstract]   [Full Text] [Related]  

  • 13. Altering lipid patterns in adult males.
    Appelbaum JJ; Amundsen MA; Perkin DK
    J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
    [No Abstract]   [Full Text] [Related]  

  • 14. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN; Ghosh P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Type V hyperlipemia. 54 cases (author's transl)].
    Schlesinger M; Jacotot B; Beaumont V; Buxtorf JC
    Nouv Presse Med; 1979 Mar; 8(11):833-7. PubMed ID: 221880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
    [No Abstract]   [Full Text] [Related]  

  • 17. [First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
    Wolfram G; Keller C; Kilani C; Zöllner N
    Verh Dtsch Ges Inn Med; 1973; 79():1291-3. PubMed ID: 4597609
    [No Abstract]   [Full Text] [Related]  

  • 18. Secholex, Clofibrate and taurine in hyperlipidaemia.
    Howard AN; Evans RJ
    Atherosclerosis; 1974; 20(1):105-16. PubMed ID: 4376405
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
    Dunnigan MG; Cochrane MA; Kelly A; Scott JW
    Q J Med; 1974 Jan; 43(169):33-48. PubMed ID: 4362786
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P; Schwandt P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.